Literature DB >> 16619180

Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.

Majid Laassri1, Kathleen Lottenbach, Robert Belshe, Margaret Rennels, Stanley Plotkin, Konstantin Chumakov.   

Abstract

Replication of Sabin strains used in oral poliovirus vaccine (OPV) in the intestines of vaccine recipients leads to reversions that increase virus neurovirulence. Previously, a small study reported that prior immunization with inactivated poliovirus vaccine (IPV) resulted in faster accumulation of revertant virus, thus potentially increasing the risk of vaccine-associated paralytic poliomyelitis. We studied the impact that prior immunization with IPV and OPV has on shedding of revertant virus by healthy infants. By polymerase chain reaction (PCR), we amplified full-length poliovirus genomes directly from stool specimens from unimmunized infants and from infants previously immunized with IPV or OPV. The amplicons were used to quantify reversions in the 5'-untranslated region, using oligonucleotide microarray hybridization. Nearly all 140 samples that were PCR positive contained varying amounts of revertants of all 3 poliovirus serotypes. Polioviruses of Sabin types 2 and 3 reverted more easily than those of type 1. Prior vaccination with IPV did not increase the proportion of revertants after OPV administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619180     DOI: 10.1086/503366

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay.

Authors:  Devasena Gnanashanmugam; Meira S Falkovitz-Halpern; Anthony Dodge; Melanie Fang; Lisa J Wong; Melissa Esparza; Rebecca Hammon; Enrique E Rivas-Merelles; Jose I Santos; Yvonne Maldonado
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

2.  Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Jong-Hoon Kim; Cara C Burns; Olen M Kew; M Steven Oberste; Ousmane M Diop; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-07       Impact factor: 4.000

3.  Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.

Authors:  Agustín Ciapponi; Ariel Bardach; Lucila Rey Ares; Demián Glujovsky; María Luisa Cafferata; Silvana Cesaroni; Aikant Bhatti
Journal:  Cochrane Database Syst Rev       Date:  2019-12-05

4.  The 5' untranslated region as a pathogenicity determinant of Semliki Forest virus in mice.

Authors:  Christopher H Logue; Brian J Sheahan; Gregory J Atkins
Journal:  Virus Genes       Date:  2008-02-09       Impact factor: 2.332

5.  Estimating the risk of re-emergence after stopping polio vaccination.

Authors:  Akira Sasaki; Yoshihiro Haraguchi; Hiromu Yoshida
Journal:  Front Microbiol       Date:  2012-05-21       Impact factor: 5.640

6.  Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.

Authors:  Christopher van Hoorebeke; ChunHong Huang; Sean Leary; Marisa Holubar; Jonathan Altamirano; Meira S Halpern; Marvin Sommer; Yvonne Maldonado
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

7.  Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2.

Authors:  Hasmik Manukyan; Erman Tritama; Rahnuma Wahid; Azeem Ansari; John Konz; Konstantin Chumakov; Majid Laassri
Journal:  Vaccines (Basel)       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.